What:The second AACR-IASLC Joint Conference on Molecular Origins of Lung Cancer: Biology, Therapy and Personalized Medicine will bring together scientists to share the latest findings in the diagnosis, treatment and prevention of the nation’s leading cause of cancer and cancer mortality.
The conference, scheduled for Jan. 8-11, 2012, in San Diego, is jointly sponsored by the American Association for Cancer Research and the International Association for the Study of Lung Cancer.
The conference will feature a series of groundbreaking oral presentations and hundreds of abstracts including:
• prevention of tobacco damage using antiestrogens;• the role of tumor suppressor genes in small cell lung cancer;• a phase 2 study of sorafenib in patients with stage IV disease;• new tools to measure circulating tumor cells; and• new data on microRNA and KRAS mutations.
When:Jan. 8-11, 2012
Where:San Diego Marriott Hotel & MarinaSan Diego, Calif.
Press Registration and Hotel Accommodations:To register, please visit www.aacr.org/LungCancer or contact Natalie Poole in the AACR Communications Department at [email protected] or (215) 446-7155.
RSS